Book in one sentence: A neuroscientist who scans brains for a living makes the case that Alzheimer’s is largely preventable in women, if we stop treating women’s brains like smaller male ones.
- What Is The XX Brain About?
- Why Do Women Get Alzheimer’s at Twice the Rate?
- What Does Estrogen Actually Do in the Brain?
- What Should Women Actually Eat for Brain Health?
- Is The XX Brain Worth Reading?
- Books Like The XX Brain
What Is The XX Brain About?
If you’ve ever walked into a room and forgotten why you went there, your doctor probably smiled and said “that happens to everyone.” Maybe it does. But Lisa Mosconi’s research suggests it happens more to women, more often, starting earlier. There’s a measurable biological reason why. She’s not guessing. She’s been scanning women’s brains for two decades at Weill Cornell Medicine, where she’s associate director of the first Alzheimer’s Prevention Clinic in the United States.
Here’s the statistic she opens with: two-thirds of all Alzheimer’s patients in the U.S. are women. A 60-year-old woman is twice as likely to develop Alzheimer’s in her remaining lifetime as she is to develop breast cancer. Her mother developed it. Her grandmother developed it. She wrote this book because medicine has spent generations treating women’s brains as though they were simply smaller male brains, and the consequences of that assumption are now showing up in the numbers.
The XX Brain makes a specific, evidence-backed argument: the brain fog, memory slips, sleep disruption, and mood changes that women experience in perimenopause are not “just aging.” They show up on brain scans. They correspond to real metabolic changes. And they are, in many cases, the earliest detectable signal of Alzheimer’s risk (occurring 20 to 30 years before anyone would ever be diagnosed). The good news buried inside that alarming fact is that the window for doing something about it is long, and most of the interventions are free.
Why Do Women Get Alzheimer’s at Twice the Rate?
The standard answer is that women live longer. Mosconi’s answer is: that’s not the whole story.
Women carry a distinct Alzheimer’s vulnerability that has nothing to do with longevity and everything to do with biology. Women are more likely to carry the APOE-4 gene variant (the main genetic risk factor for Alzheimer’s). They’re more likely to develop tau pathology. Their hippocampuses (the brain’s memory center) atrophy faster once the disease begins. And because women’s verbal memory systems are so strong, early Alzheimer’s pathology can be masked for years while it accumulates silently.
There’s also a myth Mosconi dismantles cleanly: Alzheimer’s is not genetic destiny. Only 1-2% of cases come from rare deterministic mutations. For the remaining 98%, risk is built from a combination of genetics, hormones, medical history, and daily choices over decades. APOE-4 is a susceptibility factor, not a sentence. The modifiable risks (cardiovascular disease, type 2 diabetes, obesity, hypertension, chronic stress, sleep deprivation, poor diet) account for a substantial share of Alzheimer’s cases. Every one of them is addressable.
The hard part is timing. By the time someone gets an Alzheimer’s diagnosis, pathology has been accumulating for two or three decades. The brain scan changes Mosconi’s lab detects in perimenopausal women (reduced glucose metabolism in memory and reasoning centers) look strikingly similar to what they see in early Alzheimer’s. That’s not a reason to panic. It’s a reason to act in your 40s, not your 70s.
What Does Estrogen Actually Do in the Brain?
Most people think of estrogen as a reproductive hormone. That framing is wrong, and Mosconi spends the first quarter of the book correcting it.
Estrogen is a neurological hormone. Estrogen receptors are distributed throughout the brain: the hippocampus, prefrontal cortex, amygdala, and brainstem. Through those receptors, estrogen governs how the brain fuels itself, manages inflammation, builds new synaptic connections, and regulates serotonin, GABA, and endorphins. Mosconi calls it the brain’s “master regulator.” When it declines during perimenopause, the brain’s energy supply falters and its defenses weaken.
“Estrogen is a ‘master regulator’ in the female brain, serving many roles that actually have nothing to do with reproduction, but rather everything to do with energy.”
This reframe matters because it changes how to interpret what’s happening during the menopausal transition. Perimenopause is not just a reproductive event. It’s a neurological one. The brain fog is real. The memory lapses are real. The mood volatility is real. These are not character flaws or signs that you’re “losing it.” They’re measurable metabolic changes that show up on imaging.
Mosconi also takes on the hormone therapy mess left by the 2002 Women’s Health Initiative trials, which spooked a generation of women and doctors away from menopausal hormone therapy (MHT). The WHI studied women averaging 63 years old (more than a decade past menopause) given synthetic progestins and conjugated equine estrogen derived from pregnant mares. The results were applied to all women, everywhere, forever. That was the error. The “timing hypothesis,” supported by substantial research since, holds that MHT begun during perimenopause or early menopause (when estrogen receptors are still active) carries a very different risk profile. Women who start it in that window show reduced cardiovascular risk, preserved cognitive function, and in several studies, reduced Alzheimer’s risk. Transdermal estradiol and micronized progesterone carry less risk than the formulations studied in the WHI. Mosconi isn’t telling every woman to take hormones. She’s giving women enough information to have a real conversation with their doctor.
What Should Women Actually Eat for Brain Health?
Mosconi is a neuroscientist who studies diet and the brain, so her nutrition chapter is grounded in actual research rather than the usual “eat whole foods” non-advice. The framework is built on Mediterranean and MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet research, with adjustments specific to women’s hormonal and metabolic needs.
The headline findings:
- Dark leafy greens, daily. One serving per day is associated with cognitive function 11 years younger than in women who rarely eat them. The active components are vitamins K, folate, and lutein.
- Berries, twice a week. Blueberries and strawberries specifically, based on a 16,000-woman study showing 2.5 years of slower cognitive aging with two or more weekly servings. Flavonoids are the mechanism.
- Fatty fish, 2-3 times a week. Omega-3s (EPA and DHA) are critical for brain membrane structure and anti-inflammatory signaling. Low omega-3 index in women predicts accelerated cognitive aging.
- Fiber, 25+ grams daily. Women’s estrogen metabolism depends on gut bacteria that require adequate fiber. Fiber also stabilizes blood glucose, which directly reduces brain inflammation.
- Olive oil as primary fat. The Mediterranean-MIND trials with the strongest cognitive outcome data all center on olive oil.
The surprises are what to cut. Refined grains, added sugar, ultra-processed food: expected. Alcohol is the one that lands differently. Even one drink per day is associated with measurable brain shrinkage in women. The “a glass of wine is protective” narrative does not hold up in neuroimaging research. Mosconi doesn’t moralize about it; she just reports what the scans show.
On exercise: 40 minutes of brisk walking three times per week grew hippocampal volume by 2% in one year in a clinical trial she cites (Kirk Erickson’s 2011 study). The stretching-only control group showed the normal 1-2% annual brain shrinkage. Walking as if late for a meeting, three times a week, rolled back cognitive age by approximately two years. No gym, no equipment, no elite fitness required.
Sleep and stress get real treatment too. Chronic cortisol exposure damages brain tissue. Seven to nine hours of sleep is when the glymphatic system flushes amyloid and tau (the proteins that cause Alzheimer’s). Social isolation is an independent Alzheimer’s risk factor of similar magnitude to cardiovascular disease. Scheduling time with friends is, by this research, a legitimate brain health intervention.
Is The XX Brain Worth Reading?
Read this if you’re a woman in your 30s, 40s, or 50s who wants to understand what’s actually happening in your brain as your hormones shift. If you’ve ever been dismissed when reporting brain fog, memory issues, or mood disruption around perimenopause. If you have a maternal family history of Alzheimer’s and want a concrete prevention framework. If you’ve avoided or feel confused about hormone therapy because of the 2002 WHI scare.
Skip it if you want a quick-read checklist with no science. Mosconi writes for an educated general audience, but this is not a 10-minute skim. She is translating FDG-PET imaging and genomic research into plain language, and that takes some patience.
One caveat: Published in 2020, so the MHT and APOE-4 research landscape has continued to move. Readers with specific questions about hormone therapy should check current clinical guidelines alongside this book, not instead of them. Mosconi’s follow-up, The Menopause Brain (2024), deepens the hormonal transition content with more recent data.
Books Like The XX Brain
| Book | Author | Best For |
|---|---|---|
| The Menopause Brain | Lisa Mosconi | Mosconi’s 2024 follow-up focused on the menopausal transition specifically |
| Brain Food | Lisa Mosconi | Her 2018 book with deeper nutritional science for brain health |
| Brain Body Diet | Sara Gottfried, MD | Hormonal drivers of women’s brain and metabolic health |
| The Menopause Manifesto | Jen Gunter, MD | Evidence-based guide to menopause without the fear |
| Hormone Intelligence | Aviva Romm, MD | Integrative approach to women’s hormonal health across the lifespan |